Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Zhongguo Zhong Yao Za Zhi ; 48(9): 2273-2283, 2023 May.
Artículo en Zh | MEDLINE | ID: mdl-37282856

RESUMEN

The active ingredients in traditional Chinese medicine(TCM)are the foundation for the efficiency of TCM and the key to the formation of Dao-di herbs. It is of great significance to study the biosynthesis and regulation mechanisms of these active ingredients for analyzing the formation mechanism of Daodi herbs and providing components for the production of active ingredients in TCM by synthetic biology. With the advancements in omics technology, molecular biology, synthetic biology, artificial intelligence, etc., the analysis of biosynthetic pathways for active ingredients in TCM is rapidly progressing. New methods and technologies have promoted the analysis of the synthetic pathways of active ingredients in TCM and have also made this area a hot topic in molecular pharmacognosy. Many researchers have made significant progress in analyzing the biosynthetic pathways of active ingredients in TCM such as Panax ginseng, Salvia miltiorrhiza, Glycyrrhiza uralensis, and Tripterygium wilfordii. This paper systematically reviewed current research me-thods for analyzing the biosynthetic functional genes of active ingredients in TCM, elaborated the mining of gene elements based on multiomics technology and the verification of gene functions in plants in vitro and in vivo with candidate genes as objects. Additionally, the paper summarized new technologies and methods that have emerged in recent years, such as high-throughput screening, molecular probes, genome-wide association studies, cell-free systems, and computer simulation screening to provide a comprehensive reference for the analysis of the biosynthetic pathways of active ingredients in TCM.


Asunto(s)
Medicamentos Herbarios Chinos , Medicina Tradicional China , Inteligencia Artificial , Vías Biosintéticas , Simulación por Computador , Estudio de Asociación del Genoma Completo
2.
Mol Brain ; 10(1): 38, 2017 08 11.
Artículo en Inglés | MEDLINE | ID: mdl-28800762

RESUMEN

The G protein-coupled receptor 55 (GPR55) is a novel cannabinoid receptor, whose exact role in anxiety remains unknown. The present study was conducted to explore the possible mechanisms by which GPR55 regulates anxiety and to evaluate the effectiveness of O-1602 in the treatment of anxiety-like symptoms. Mice were exposed to two types of acute stressors: restraint and forced swimming. Anxiety behavior was evaluated using the elevated plus maze and the open field test. We found that O-1602 alleviated anxiety-like behavior in acutely stressed mice. We used lentiviral shRNA to selective ly knockdown GPR55 in the medial orbital cortex and found that knockdown of GPR55 abolished the anxiolytic effect of O-1602. We also used Y-27632, a specific inhibitor of ROCK, and U73122, an inhibitor of PLC, and found that both inhibitors attenuated the effectiveness of O-1602. Western blot analysis revealed that O-1602 downregulated the expression of GluA1 and GluN2A in mice. Taken together, these results suggest that GPR55 plays an important role in anxiety and O-1602 may have therapeutic potential in treating anxiety-like symptoms.


Asunto(s)
Ansiedad/metabolismo , Ansiedad/psicología , Corteza Prefrontal/metabolismo , Receptores de Cannabinoides/metabolismo , Estrés Psicológico/metabolismo , Enfermedad Aguda , Amidas/administración & dosificación , Amidas/farmacología , Amidas/uso terapéutico , Animales , Ansiolíticos/administración & dosificación , Ansiolíticos/farmacología , Ansiolíticos/uso terapéutico , Ansiedad/tratamiento farmacológico , Cannabidiol/análogos & derivados , Enfermedad Crónica , Ciclohexanos/farmacología , Ciclohexanos/uso terapéutico , Estrenos/farmacología , Técnicas de Silenciamiento del Gen , Inyecciones Intraperitoneales , Masculino , Ratones Endogámicos C57BL , Piridinas/administración & dosificación , Piridinas/farmacología , Piridinas/uso terapéutico , Pirrolidinonas/farmacología , Resorcinoles/farmacología , Resorcinoles/uso terapéutico , Restricción Física , Transducción de Señal , Estrés Psicológico/tratamiento farmacológico , Natación
3.
Int Immunopharmacol ; 41: 66-73, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27816787

RESUMEN

The analgesic effects of gastrodin (GAS), an active component derived from the Chinese herb Tian ma (Gastrodia elata Blume), on chronic inflammatory pain of mice and the involved molecular mechanisms were investigated. GAS significantly attenuated mice chronic inflammatory pain induced by hindpaw injection of complete Freund's adjuvant (CFA) and the accompanying anxiety-like behaviors. GAS administration reduced CFA-induced up-regulation of GluR1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, GluN2A- and GluN2B-containing N-methyl-d-aspartate (NMDA) receptors, and Ca2+/calmodulin-dependent protein kinase II-alpha (CaMKII-α) in the anterior cingulate cortex (ACC). The GluN2A and GluN2B subunits of NMDA receptors, the GluR1 type of AMPA receptor, and CaMKII-α are key molecules responsible for neuroplasticity involved in chronic pain and the accompanying anxiety. Moreover, GAS administration reduced the activation of astrocyte and microglia and the induction of TNF-α and IL-6 in the ACC of the CFA-injected mice. Therefore, GAS administration relieved chronic pain, exerted anxiolytic effects by regulating neuroplasticity molecules, and attenuated the inflammatory response by reducing the induction of TNF-α and IL-6 in the ACC of the CFA-injected mice.


Asunto(s)
Analgésicos/uso terapéutico , Ansiolíticos/uso terapéutico , Antiinflamatorios/uso terapéutico , Alcoholes Bencílicos/uso terapéutico , Glucósidos/uso terapéutico , Hiperalgesia/tratamiento farmacológico , Dolor/tratamiento farmacológico , Analgésicos/farmacología , Animales , Ansiolíticos/farmacología , Antiinflamatorios/farmacología , Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Alcoholes Bencílicos/farmacología , Proteínas de Unión al Calcio/metabolismo , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/metabolismo , Adyuvante de Freund , Proteína Ácida Fibrilar de la Glía/metabolismo , Glucósidos/farmacología , Giro del Cíngulo/efectos de los fármacos , Giro del Cíngulo/metabolismo , Calor , Hiperalgesia/inducido químicamente , Hiperalgesia/metabolismo , Interleucina-6/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas de Microfilamentos/metabolismo , Microglía/efectos de los fármacos , Microglía/metabolismo , Dolor/inducido químicamente , Dolor/metabolismo , Receptores AMPA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Tacto , Factor de Necrosis Tumoral alfa/metabolismo
4.
Biotechnol Lett ; 26(11): 885-90, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15269535

RESUMEN

To produce an industrial strain of Saccharomyces cerevisiae that metabolizes xylose, we constructed a rDNA integration vector and YIp integration vector, containing the xylose-utilizing genes, XYL1 and XYL2, which encode xylose reductase (XR) and xylitol dehydrogenase (XDH) from Pichia stipitis, and XKS1, which encodes xylulokinase (XK) from S. cerevisiae, with the G418 resistance gene KanMX as a dominant selectable marker. The rDNA results in integration of multiple copies of the target genes. The industrial stain of S. cerevisiae NAN-27 was transformed with the two integration vectors to produce two recombinant strains, S. cerevisiae NAN-127 and NAN-123. Upon transformation, multiple copies of the xylose-utilizing genes were integrated into the genome rDNA locus of S. cerevisiae. Strain NAN-127 consumed twice as much xylose and produced 39% more ethanol than the parent strain, while NAN-123 consumed 10% more xylose and produced 10% more ethanol than the parent strain over 94 h.


Asunto(s)
Etanol/metabolismo , Mejoramiento Genético/métodos , Microbiología Industrial/métodos , Ingeniería de Proteínas/métodos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Xilosa/metabolismo , Proliferación Celular , Proteínas Recombinantes/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Transducción de Señal/fisiología , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA